CymaBay Down on Dismal Interim Data From Mid-Stage NASH Study

Original post

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Conatus Pharmaceuticals Inc. (CNAT): Free Stock Analysis Report
 
Intercept Pharmaceuticals, Inc. (ICPT): Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD): Free Stock Analysis Report
 
CymaBay Therapeutics Inc. (CBAY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research